Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.77
+3.49 (1.54%)
AAPL  277.72
+1.80 (0.65%)
AMD  201.00
-14.05 (-6.53%)
BAC  52.78
+0.85 (1.65%)
GOOG  322.18
+3.71 (1.17%)
META  633.11
+20.06 (3.27%)
MSFT  477.00
+3.00 (0.63%)
NVDA  176.56
-5.99 (-3.28%)
ORCL  194.81
-5.47 (-2.73%)
TSLA  417.38
-0.40 (-0.09%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.